Caroline Geers

Academic, Medicine and Pharmacy academic/administration
Laboratory of Molecular and Medical Oncology
UZB Physician, Pathology

https://orcid.org/0000-0002-9389-8803

Pleinlaan 2
1050 Brussels
Belgium
Laarbeeklaan 101
1090 Jette
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise

Nephropathology

Lung and pleura pathology

Head and Neck pathology

Uropathology

Fingerprint

Dive into the research topics where Caroline Geers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

14 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

685 Citations
10 h-Index
25 Article
5 Editorial
3 Meeting abstract (Journal)
1 Poster

5-Year outcomes of the prospective and randomized cistcert study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients
Pipeleers, L., Abramowicz, D., Broeders, N., Lemoine, A., Peeters, P., Van Laecke, S., Weekers, L. E., Sennesael, J., Wissing, K. M., Geers, C. & Bosmans, J-L., Feb 2021, In : Transplant International. 34, 2, p. 313-326 14 p.
Research output: Contribution to journal › Article
Encrusted Uropathy: A Comprehensive Overview-To the Bottom of the Crust
Van de Perre, E., Reichman, G., De Geyter, D., Geers, C., Wissing, K. M. & Letavernier, E., 2020, In : Frontiers in Medicine. 7, 14 p., 609024.
Research output: Contribution to journal › Article
Sebaceous Adenoma of the Parotis Gland
Sahebali, S., De Smet, S. J., Geers, C., Waelput, W., Lefesvre, P. & Forsyth, R., 18 Oct 2019.
Research output: Unpublished contribution to conference › Poster
Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer
Umelo, I., Noeparast, A., Chen, G., Renard, M., Geers, C., Vansteenkiste, J., Giron, P., De Wever, O., Teugels, E. & De Grève, J., 19 Jan 2016, In : Oncotarget. 7, 3, p. 3068-3083 16 p.
Research output: Contribution to journal › Article
16 Citations (Scopus)
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)
De Grève, J., Van Meerbeeck, J., Vansteenkiste, J. F., Decoster, L., Meert, A-P., Vuylsteke, P., Focan, C., Canon, J-L., Humblet, Y., Berchem, G., Colinet, B., Galdermans, D., Bosquée, L., Vermeij, J., Dewaele, A., Geers, C., Schallier, D. & Teugels, E., 2016, In : PLoS ONE. 11, 3, 14 p., e0147599.
Research output: Contribution to journal › Article
16 Citations (Scopus)

Expertise

5-Year outcomes of the prospective and randomized cistcert study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients

Encrusted Uropathy: A Comprehensive Overview-To the Bottom of the Crust

Sebaceous Adenoma of the Parotis Gland

Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)